Presentations by Kris Oreschak

• Tue-05 from 16:30 - 17:45 in room 20
  The Future of Heart Transplant Surveillance?
  Prognostic Value of Donor-Derived Cell-Free DNA in Combination with HLA1 and HLA2 Donor Specific Antibodies After Heart Transplant
• Tue-05 from 16:30 - 17:45 in room 20
  The Future of Heart Transplant Surveillance?
  Leveraging Longitudinal Donor-Derived Cell-Free DNA and Gene Expression Profiling Data for Acute Cellular Rejection Diagnosis After Heart Transplant
• Tue-05 from 16:30 - 17:45 in room 20
  The Future of Heart Transplant Surveillance?
  Antibody Mediated Rejection in the Contemporary Donor-Derived Cell-Free DNA Era: An Analysis of the Surveillance HeartCare Outcomes Registry
• Tue-05 from 16:30 - 17:45 in room 20
  The Future of Heart Transplant Surveillance?
  Impact of Persistently Elevated Simultaneous Gene Expression Profiling and Donor-Derived Cell-Free DNA on Future Clinical Events